We are at a watershed brought on by the recent introduction of highly effective obesity medications. As the development of these medications continues to evolve, obesity research will hold a prominent position over the next several decades. These new pharmacotherapeutics can potentially help transform the lives and health of people with obesity, and hold promise for the health of our nation and world.
Yale Obesity Research Center (Y-Weight)
The United States is at the forefront of the global obesity epidemic with estimates indicating that half of Americans will have obesity by 2030 (body mass index =30kg/m2). Obesity is a complex, chronic disease in and of itself and, additionally, it has driven substantial increases in obesity-related conditions, such as Type 2 diabetes, cardiovascular disease, and even some types of cancer.
How to Help
The question is, why wait? The needs are incredibly clear. We need to discover and develop new medication to provide tools for clinicians and treatment options for people living with obesity. We are all in this together, participants, researchers, patients, clinicians. Together, we can move forward on every front. Join us!
Y-Weight Research
The focus of Y-Weight (the Yale Obesity Research Center) is to investigate novel obesity medications and to use these medications to help us better understand the biology of obesity. The three areas of clinical research at Y-Weight include: 1) human physiology studies (to better understand the biology of obesity), 2) clinical trials (to assess the efficacy and safety of novel obesity medications), and 3) outcomes research (to investigate how these medications are used work in the real-world and impact population health).
- December 31, 2025Source: People
Oprah Opens Up About Obesity, GLP-1s and Her Healthy New Life
- December 31, 2025Source: People
Oprah's Co-Author Says Icon Turned Blame and Shame She Faced into a 'Gift' for Others with Obesity
- December 04, 2025
Meet Alexandra Tavakoli, Associate Director of Operations (Endocrinology and Metabolism)
- November 27, 2025Source: Washington Post
Ozempic 2.0 is on the way, and it could be even more transformative